SCN1A and epilepsy: These precision diagnoses support the development of personalized therapies by providing insights into genotype‒phenotype relationships; for example, we would not use SCBs in SCN1A‐related epilepsy (Brunklaus, Ellis, Reavey, Forbes, & Zuberi, 2012).